Trusted medical expertise in seconds.

Access 1,000+ clinical and preclinical articles. Find answers fast with the high-powered search feature and clinical tools.

Try free for 5 days
Evidence-based content, created and peer-reviewed by physicians. Read the disclaimer.

Rheumatoid arthritis

Last updated: August 13, 2020

Summarytoggle arrow icon

Rheumatoid arthritis (RA) is an inflammatory autoimmune disorder characterized by joint pain, swelling, and synovial destruction. RA predominantly affects middle-aged women. The condition can also cause various extra-articular manifestations such as rheumatoid nodules and pulmonary fibrosis. Diagnosis is mainly based on clinical features (e.g., morning stiffness, symmetrical joint swelling) and laboratory tests (e.g., anti-CCP). X-ray findings (e.g., soft tissue swelling or joint space narrowing) occur late in the disease and are therefore not typically used for diagnosis. Early intervention with disease-modifying antirheumatic drugs (DMARDs) plays a decisive role in successful treatment. RA is not curable, but early effective treatment may help offset severe complications (e.g., permanent damage to the affected joints).

  • Prevalence: ∼ 1% in Caucasians; lower in African and Chinese population [1]
  • Sex: > (3:1)
  • Peak incidence: 30–50 years

References:[2][3]

Epidemiological data refers to the US, unless otherwise specified.

  • Chronic inflammatory autoimmune disorder of unknown etiology
  • Hypotheses suggest the etiology is multifactorial, with the following factors playing a role:
    • Genetic disposition; : RA appears to be associated with specific HLA types (HLA-DR4, HLA-DR1). [4].
    • Environmental triggers (e.g., infection, tobacco)
    • Hormonal factors

References:[5][6]

  • Initially, non-specific inflammation affects the synovial tissue, which is later amplified by activation of T cells (autoimmune response).
  • With time, it may lead to inflammatory joint effusion and synovial hypertrophy, as well as progressive destruction and deterioration of cartilage and bone.
  • Patients with positive rheumatoid factor (RF) are more likely to develop extra-articular manifestations of rheumatoid arthritis. [7]

References:[8][9]

Articular manifestations

DIP joints are not typically affected in RA!

Extra-articular manifestations

References:[6][12][13][14][15][16][17]

RA of the cervical spine [10]

RA normally spares the thoracic and lumbar spine. In some cases, it initially affects the cervical spine, causing early-morning neck pain at rest.

Felty syndrome [10]

If a patient has arthritis, splenomegaly, and neutropenia, consider Felty syndrome.

Other subtypes

References:[18][19][20][21][22]

The diagnosis of RA is based on diagnostic criteria that include laboratory testing. Imaging may support the diagnosis, but radiological joint findings are no longer included in the criteria, as they often become evident only in late stages of disease.

ACR criteria for RA (ACR/EULAR classification criteria (2010) [23]

  • Rheumatoid arthritis = score of ≥ 6 points + confirmed presence of synovitis in at least one typical joint without an alternative, more probable diagnosis (e.g., trauma or degenerative joint conditions)
    • For every column, the highest score is taken into account.
Points Joint involvement (pain/swelling) Serology Acute phase reactants Duration of symptoms*
0 ≤ 1 large joints** Negative RF and ACPA Normal CRP and ESR < 6 weeks
1 2–10 large joints CRP or ESR ≥ 6 weeks
2 1–3 small joints Low positive RF or ACPA
3 4–10 small joints High positive RF or ACPA (> three times higher than normal)
5

> 10 joints (at least one small joint)

Key

Laboratory tests

Imaging

  • Conventional x-ray
    • Dorso-palmar x-ray of both hands
    • Radiological findings
      • Early: soft tissue swelling, demineralization (juxta‑articular)
      • Late: joint space narrowing, erosions of cartilage and bone, demineralization (generalized)

Even if radiographic findings are normal, RA is still possible!

Before undergoing general anesthesia, airway and neck assessment is crucial in patients with rheumatoid arthritis. Atlanto-axial subluxation may be present, which increases the risk for spinal cord injury. Preoperative flexion-extension radiographs can help to evaluate the position of the cervical vertebra atlas (C1) with regard to the axis (C2).

References:[6][18][23][24][25][26][27][28][29]

References:[30][31][32][33]

Differential diagnoses of inflammatory arthritis

Condition:

Osteoarthritis

(most common)

Rheumatoid Arthritis (RA) Psoriatic arthritis Gout Pseudogout

Specific groups

  • Sex: >
  • Majority of people > 65 years have radiological evidence of osteoarthritis which may be asymptomatic
  • >
  • Family history of RA
  • Sex: =
  • Family or personal history of psoriasis
  • May be triggered by trauma or infections (e.g., HIV infection)
  • Sex: =
  • Mostly older patients (> 50 years)

Course of disease

  • Chronic, progressive course
  • Chronic course with varied patterns: either monocyclic, polycyclic or progressive
  • Chronic, progressive course
  • Chronic course with acute attacks (rapid onset of symptoms)

Clinical features

  • No constitutional symptoms
  • Morning stiffness < 30 minutes
  • Pain/stiffness worsens with increased activity and relieved by rest
  • Non-inflammatory
Symmetry of joint involvement
  • Usually asymmetrical
  • Symmetrical
  • Symmetrical
  • Asymmetrical
  • Asymmetrical

Pattern of disease

  • Polyarthritis or oligoarthritis
    • Commonly DIPJ and/or spinal involvement
    • Sometimes large joints
  • Usually monoarthritis: typical locations include the big toe (MTPJ), knee and thumb (MCPJ)

Other differential diagnoses:

References:[34][35]

The differential diagnoses listed here are not exhaustive.

General measures

Acute anti-inflammatory therapy

Long-term anti-inflammatory therapy with disease-modifying antirheumatic drugs (DMARDs)

Early administration of DMARDs is crucial for a better outcome!

References:[5][6][37][38][39][40][41]

Untreated and/or severe cases can result in permanent damage to the joints with stiffening and deformity.

References:[6][42][43][44][45]

We list the most important complications. The selection is not exhaustive.

  • Factors associated with poor prognosis
    • Prolonged disease progression without initiation of treatment
    • Late onset (> 60 years of age)
    • Sex:
    • Smoking
    • Social factors (e.g., low socioeconomic status, low level of education)
  • Laboratory tests associated with worsened prognosis if abnormally elevated

References:[6][40]

  1. Kumar, Clark. Kumar and Clark's Clinical Medicine, 9th edition. Elsevier ; 2016
  2. Cojocaru M, Cojocaru IM, Silosi I, Vrabie CD, Tanasescu R. Extra-articular Manifestations in Rheumatoid Arthritis. Maedica (Buchar). 2010 .
  3. Gabriel SE, Crowson CS, Maini RN, Romain PL. Epidemiology of, Risk Factors for, and Possible Causes of Rheumatoid Arthritis. In: Post TW, ed. UpToDate. Waltham, MA: UpToDate. https://www.uptodate.com/contents/epidemiology-of-risk-factors-for-and-possible-causes-of-rheumatoid-arthritis.Last updated: September 16, 2016. Accessed: October 16, 2017.
  4. Kasper DL, Fauci AS, Hauser S, Longo D, Jameson LJ, Loscalzo J . Harrisons Principles of Internal Medicine . McGraw-Hill Medical Publishing Division ; 2016
  5. Van Nies JA, Alves C, Radix-Bloemen AL, et al.. Reappraisal of the diagnostic and prognostic value of morning stiffness in arthralgia and early arthritis: results from the Groningen EARC, Leiden EARC, ESPOIR, Leiden EAC and REACH. Arthritis Res Ther. 2015; 17 (1). doi: 10.1186/s13075-015-0616-3 . | Open in Read by QxMD
  6. Smith HR. Rheumatoid Arthritis. In: Diamond HS, Rheumatoid Arthritis. New York, NY: WebMD. http://emedicine.medscape.com/article/331715-overview. Updated: July 19, 2016. Accessed: April 7, 2017.
  7. Rheumatoid Arthritis Fact Sheet. https://www.cdc.gov/arthritis/basics/rheumatoid-arthritis.html. Updated: March 13, 2017. Accessed: April 10, 2017.
  8. Hitchhiker thumb deformity. https://radiopaedia.org/articles/hitchhiker-thumb-deformity. Updated: April 10, 2017. Accessed: April 10, 2017.
  9. Matteson EL, Davis JM. Overview of the systemic and nonarticular manifestations of rheumatoid arthritis. In: Post TW, ed. UpToDate. Waltham, MA: UpToDate. https://www.uptodate.com/contents/overview-of-the-systemic-and-nonarticular-manifestations-of-rheumatoid-arthritis.Last updated: October 28, 2016. Accessed: April 10, 2017.
  10. Kim DS. Interstitial lung disease in rheumatoid arthritis: recent advances. Curr Opin Pulm Med. 2006; 12 (5): p.346-353. doi: 10.1097/01.mcp.0000239552.55326.ee . | Open in Read by QxMD
  11. Young A, Koduri G. Extra-articular manifestations and complications of rheumatoid arthritis. Best Pract Res Clin Rheumatol. 2007; 21 (5): p.907-927. doi: 10.1016/j.berh.2007.05.007 . | Open in Read by QxMD
  12. Venables PJW, Ravinder NM, O'Dell JR, Romain PL. Clinical Manifestations of Rheumatoid Arthritis. In: Post TW, ed. UpToDate. Waltham, MA: UpToDate. https://www.uptodate.com/contents/clinical-manifestations-of-rheumatoid-arthritis.Last updated: October 12, 2017. Accessed: October 16, 2017.
  13. Kasper DL, Fauci AS, Hauser SL, Longo DL, Lameson JL, Loscalzo J. Harrison's Principles of Internal Medicine. McGraw-Hill Education ; 2015
  14. Currier BL, Coblyn J. Cervical subluxation in rheumatoid arthritis. In: Post TW, ed. UpToDate. Waltham, MA: UpToDate. https://www.uptodate.com/contents/cervical-subluxation-in-rheumatoid-arthritis.Last updated: February 14, 2017. Accessed: April 10, 2017.
  15. Kay J. Role of splenectomy for Felty's syndrome. In: Post TW, ed. UpToDate. Waltham, MA: UpToDate. http://www.uptodate.com/contents/role-of-splenectomy-for-feltys-syndrome.Last updated: January 17, 2017. Accessed: April 10, 2017.
  16. Kay J, Maini RN, Romain PL. Clinical Manifestations and Diagnosis of Felty's Syndrome. In: Post TW, ed. UpToDate. Waltham, MA: UpToDate. https://www.uptodate.com/contents/clinical-manifestations-and-diagnosis-of-feltys-syndrome.Last updated: June 8, 2017. Accessed: October 16, 2017.
  17. Kay J, Maini RN, Romain PL. Drug Therapy in Felty's Syndrome. In: Post TW, ed. UpToDate. Waltham, MA: UpToDate. https://www.uptodate.com/contents/drug-therapy-in-feltys-syndrome.Last updated: January 18, 2017. Accessed: October 16, 2017.
  18. Aletaha D, Neogi T, Silman AJ, et al. 2010 Rheumatoid arthritis classification criteria: an American College of Rheumatology/European League Against Rheumatism collaborative initiative. Arthritis Rheum. 2010; 62 (9): p.2569–2581. doi: 10.1002/art.27584 . | Open in Read by QxMD
  19. Venables PJW, Maini RN. Diagnosis and differential diagnosis of rheumatoid arthritis. In: Post TW, ed. UpToDate. Waltham, MA: UpToDate. https://www.uptodate.com/contents/diagnosis-and-differential-diagnosis-of-rheumatoid-arthritis.Last updated: January 22, 2016. Accessed: April 10, 2017.
  20. Taylor PC, Maini RN. Biologic markers in the diagnosis and assessment of rheumatoid arthritis. In: Post TW, ed. UpToDate. Waltham, MA: UpToDate. https://www.uptodate.com/contents/biologic-markers-in-the-diagnosis-and-assessment-of-rheumatoid-arthritis.Last updated: June 25, 2015. Accessed: April 10, 2017.
  21. Ioan-Facsinay A, el-Bannoudi H, Scherer HU, et al. Anti-CCP antibodies are a collection of ACPA that are cross-reactive to multiple citrullinated antigen. Ann Rheum Dis. 2010; 70 (1): p.188-193. doi: 10.1136/ard.2010.131102 . | Open in Read by QxMD
  22. Rheumatoid arthritis (musculoskeletal manifestations). https://radiopaedia.org/articles/rheumatoid-arthritis-musculoskeletal-manifestations-2. Updated: April 10, 2017. Accessed: April 10, 2017.
  23. Tsou IYY. Rheumatoid Arthritis Hand Imaging. Rheumatoid Arthritis Hand Imaging. New York, NY: WebMD. http://emedicine.medscape.com/article/401271-overview. Updated: September 28, 2016. Accessed: April 10, 2017.
  24. Lopez-Olivo MA, Andrabi TR, Palla SL, Suarez-Almazor ME. Cervical spine radiographs in patients with rheumatoid arthritis undergoing anesthesia. J Clin Rheumatol. 2012; 18 (2): p.61-66. doi: 10.1097/rhu.0b013e318247bb0d . | Open in Read by QxMD
  25. Davis JM, O'Dell JR, Romain PL. Rheumatoid Nodules. In: Post TW, ed. UpToDate. Waltham, MA: UpToDate. https://www.uptodate.com/contents/rheumatoid-nodules.Last updated: August 8, 2017. Accessed: October 16, 2017.
  26. Le T, Bhushan V,‎ Sochat M, Chavda Y, Zureick A. First Aid for the USMLE Step 1 2018. McGraw-Hill Medical ; 2017
  27. Gravallese EM, Chopra R. Synovial Pathology in Rheumatoid Arthritis. In: Post TW, ed. UpToDate. Waltham, MA: UpToDate. https://www.uptodate.com/contents/synovial-pathology-in-rheumatoid-arthritis.Last updated: November 28, 2017. Accessed: October 21, 2018.
  28. Bresnihan B. Are synovial biopsies of diagnostic value?. Arthritis Res Ther. 2003; 5 (6): p.271. doi: 10.1186/ar1003 . | Open in Read by QxMD
  29. Rothschild BM. Gout and Pseudogout. Gout and Pseudogout. New York, NY: WebMD. http://emedicine.medscape.com/article/329958-overview. Updated: March 31, 2017. Accessed: April 10, 2017.
  30. Saadeh CK. Calcium Pyrophosphate Deposition Disease. Calcium Pyrophosphate Deposition Disease. New York, NY: WebMD. http://emedicine.medscape.com/article/330936-overview. Updated: July 15, 2016. Accessed: April 10, 2017.
  31. Joel M Kremer. Major Side Effects of Low-Dose Methotrexate. In: Post TW, ed. UpToDate. Waltham, MA: UpToDate. https://www.uptodate.com/contents/major-side-effects-of-low-dose-methotrexate?source=search_result&search=mtx&selectedTitle=5~150.Last updated: February 5, 2018. Accessed: December 6, 2017.
  32. Agabegi SS, Agabegi ED. Step-Up To Medicine. Lippincott Williams & Wilkins ; 2013
  33. Wasserman AM. Diagnosis and Management of Rheumatoid Arthritis. Am Fam Physician. 2011; 84 (11): p.1245-1252.
  34. Finckh A, Liang MH, van Herckenrode CM, de Pablo P. Long-term impact of early treatment on radiographic progression in rheumatoid arthritis: A meta-analysis. Arthritis Rheum. 2006; 55 (6): p.864-872. doi: 10.1002/art.22353 . | Open in Read by QxMD
  35. Singh JA, Furst DE, Bharat A. 2012 Update of the 2008 American College of Rheumatology (ACR) Recommendations for the use of Disease-Modifying Anti-Rheumatic Drugs and Biologics in the treatment of Rheumatoid Arthritis (RA). Arthritis Care Res (Hoboken). 2012 . doi: 10.1002/acr.21641 . | Open in Read by QxMD
  36. Moreland LW, Cannella A, O'Dell JR, Romain PL. General Principles of Management of Rheumatoid Arthritis in Adults. In: Post TW, ed. UpToDate. Waltham, MA: UpToDate. https://www.uptodate.com/contents/general-principles-of-management-of-rheumatoid-arthritis-in-adults.Last updated: July 22, 2016. Accessed: October 16, 2017.
  37. Cohen S, Mikuls TR, O'Dell JR, Romain PL. Initial Treatment of Rheumatoid Arthritis in Adults. In: Post TW, ed. UpToDate. Waltham, MA: UpToDate. https://www.uptodate.com/contents/initial-treatment-of-rheumatoid-arthritis-in-adults.Last updated: July 11, 2016. Accessed: October 16, 2017.
  38. Brusch JL. Septic Arthritis. In: Stuart Bronze M, Septic Arthritis. New York, NY: WebMD. http://emedicine.medscape.com/article/236299. Updated: October 21, 2016. Accessed: March 1, 2017.
  39. Turner DE, Helliwell PS, Emery P, Woodburn J. The impact of rheumatoid arthritis on foot function in the early stages of disease: a clinical case series. BMC Musculoskelet Disord. 2006; 7 : p.102. doi: 10.1186/1471-2474-7-102 . | Open in Read by QxMD
  40. Septic Arthritis. http://www.clevelandclinicmeded.com/medicalpubs/diseasemanagement/rheumatology/septic-arthritis/. Updated: August 1, 2010. Accessed: April 10, 2017.
  41. Haugeberg G, Ørstavik RE, Kvien TK. Effects of Rheumatoid Arthritis on Bone. Curr Opin Rheumatol. 2003; 15 (4): p.469-475.
  42. van Zeben D, Hazes JM, Zwinderman AH, Cats A, van der Voort EA, Breedveld FC. Clinical significance of rheumatoid factors in early rheumatoid arthritis: results of a follow up study.. Ann Rheum Dis. 1992; 51 (9): p.1029-35.
  43. Smolen JS, Kalden JR, Maini RN. Rheumatoid Arthritis: Recent Research Advances. Springer-Verlag ; 1992
  44. Firestein GS. Pathogenesis of rheumatoid arthritis. In: Post TW, ed. UpToDate. Waltham, MA: UpToDate. https://www.uptodate.com/contents/pathogenesis-of-rheumatoid-arthritis.Last updated: April 14, 2016. Accessed: April 7, 2017.
  45. Alvarez I, Collado J, Daura X, et al. The rheumatoid arthritis-associated allele HLA-DR10 (DRB1*1001) shares part of its repertoire with HLA-DR1 (DRB1*0101) and HLA-DR4 (DRB*0401). Arthritis Rheum. 2008; 58 (6): p.1630-1639. doi: 10.1002/art.23503 . | Open in Read by QxMD
  46. Walther J van Venrooij, Ger J M Pruijn. Citrullination: a small change for a protein with great consequences for rheumatoid arthritis. Arthritis Res. 2000; 2 (4): p.249. doi: 10.1186/ar95 . | Open in Read by QxMD
  47. Scott DL, Wolfe F, Huizinga TW. Rheumatoid arthritis. The Lancet. 2010; 376 (9746): p.1094-1108. doi: 10.1016/s0140-6736(10)60826-4 . | Open in Read by QxMD
  48. Singh JA, Saag KG, Bridges SL, et al. 2015 American College of Rheumatology Guideline for the Treatment of Rheumatoid Arthritis. Arthritis Care & Research. 2015; 68 (1): p.1-25. doi: 10.1002/acr.22783 . | Open in Read by QxMD
  49. Song YW, Kang EH. Autoantibodies in rheumatoid arthritis: rheumatoid factors and anticitrullinated protein antibodies. QJM. 2009; 103 (3): p.139-146. doi: 10.1093/qjmed/hcp165 . | Open in Read by QxMD
  50. Myasoedova E, Davis JM, Crowson CS, Gabriel SE. Epidemiology of Rheumatoid Arthritis: Rheumatoid Arthritis and Mortality. Curr Rheumatol Rep. 2010; 12 (5): p.379-385. doi: 10.1007/s11926-010-0117-y . | Open in Read by QxMD
  51. Whiting PF. Systematic Review: Accuracy of Anti–Citrullinated Peptide Antibodies for Diagnosing Rheumatoid Arthritis. Ann Intern Med. 2010; 152 (7): p.456. doi: 10.7326/0003-4819-152-7-201004060-00010 . | Open in Read by QxMD
  52. Agha-Abbaslou M, Bensaci AM, Dike O, Poznansky MC, Hyat A. Adult-Onset Still’s Disease: Still a Serious Health Problem (a Case Report and Literature Review). American Journal of Case Reports. 2017; 18 : p.119-124. doi: 10.12659/ajcr.901846 . | Open in Read by QxMD
  53. Rawla P. Cardiac and vascular complications in rheumatoid arthritis. Reumatologia/Rheumatology. 2019; 57 (1): p.27-36. doi: 10.5114/reum.2019.83236 . | Open in Read by QxMD
  54. Jabs DA, Mudun A, Dunn JP, Marsh MJ. Episcleritis and scleritis: clinical features and treatment results. Am J Ophthalmol. 2000; 130 (4): p.469-476. doi: 10.1016/s0002-9394(00)00710-8 . | Open in Read by QxMD
  55. Steinbrocker et al.. Therapeutic criteria in rheumatoid arthritis. JAMA: The Journal of the American Medical Association. 1949; 140 (8): p.659. doi: 10.1001/jama.1949.02900430001001 . | Open in Read by QxMD